betamethasone
Ligand Summary
A glucocorticoid given orally, parenterally, by local injection, by inhalation, or applied topically in the management of various disorders in which corticosteroids are indicated. Its lack of mineralocorticoid properties makes betamethasone particularly suitable for treating cerebral edema and congenital adrenal hyperplasia. (From Martindale, The Extra Pharmacopoeia, 30th ed, p724)
UNII: 9842X06Q6M
PubChem: 9782
Guide to Pharmacology: 7061
ChEMBL: CHEMBL632
DrugCentral: 348
LyCHI: M1RXVT6UDFF1
Target Activities
4 Activities
Items per page:
10
1 – 4 of 4
Activity Type | Activity Value -log(M) | Mechanism of Action | Activity Reference | Publications (PubMed IDs) | ||
---|---|---|---|---|---|---|
IC50 | ||||||
Ki | ||||||
IC50 | ||||||
IC50 | AGONIST | |||||